Prevencio Overview

  • Founded
  • 2006
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Series B1
  • Latest Deal Amount
  • $10M
Latest Deal Amount

Prevencio General Information


Developer of multi-proteomic biomarkers designed to revolutionize blood tests for cardiovascular disease. The company's biomarkers employ artificial intelligence to interrogate well-characterized clinical data sets to produce novel, multi-protein, algorithmically-scored tests, enabling clinicians to assess pre-drug or post-drug effects on a composite of heart attack, stroke, and cardiac death.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 11335 North East 122nd Way
  • Suite 105
  • Kirkland, WA 98034
  • United States
+1 (425) 000-0000

Prevencio Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prevencio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B1) 17-Mar-2020 $10M 000.00 Completed Clinical Trials - General
3. Later Stage VC 31-Aug-2018 000 000.00 Completed Clinical Trials - General
2. Later Stage VC (Series B) 30-Jun-2016 $4.8M $6.8M 000.00 Completed Startup
1. Later Stage VC (Series A) 30-Dec-2013 $2M $2M 000 Completed Startup
To view Prevencio’s complete valuation and funding history, request access »

Prevencio Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00 00 00 00
Series A 0,000,000 00.000000 00 00.0 00.0 00 00.0
To view Prevencio’s complete cap table history, request access »

Prevencio Executive Team (10)

Name Title Board Seat Contact Info
Rhonda Rhyne Chief Executive Officer, President & Board Member
Michele McCarthy Chief Financial Officer & Board Member
Grady Barnes Ph.D Chief Scientific Officer
William LaFramboise Ph.D Co-Founder & Consultant
Craig Magaret Chief Analytics Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Prevencio Board Members (7)

Name Representing Role Since
Arlen Prentice Self Board Observer 000 0000
John Cramer III Prevencio Board Member 000 0000
Joseph Strecker Self Board Observer 000 0000
Michele McCarthy Prevencio Chief Financial Officer & Board Member 000 0000
Rhonda Rhyne Prevencio Chief Executive Officer, President & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Prevencio Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial